The primary efficacy measure was the proportion of patients meeting treatment failure criteria ( 50 % increase in ADHD Rating Scale IV total score and 2-point increase in Clinical Global Impressions-Severity of Illness [ CGI-S ] score , compared with RWP start point ) .